Late activation of the Raf/MEK/ERK pathway is required for translocation of the respiratory syncytial virus F protein to the plasma membrane and efficient viral replication

Cellular Microbiology
Hannah F PreugschasChristina Ehrhardt

Abstract

Activation of the Raf/MEK/ERK cascade is required for efficient propagation of several RNA and DNA viruses, including human respiratory syncytial virus (RSV). In RSV infection, activation of the Raf/MEK/ERK cascade is biphasic. An early induction within minutes after infection is associated with viral attachment. Subsequently, a second activation occurs with, so far, unknown function in the viral life cycle. In this study, we aimed to characterise the role of Raf/MEK/ERK-mediated signalling during ongoing RSV infection. Our data show that inhibition of the kinase MEK after the virus has been internalised results in a reduction of viral titers. Further functional investigations revealed that the late-stage activation of ERK is required for a specific step in RSV replication, namely, the secretory transport of the RSV fusion protein F. Thus, MEK inhibition resulted in impaired surface accumulation of the F protein. F protein surface expression is essential for efficient replication as it is involved in viral filament formation, cell fusion, and viral transmission. In summary, we provide detailed insights of how host cell signalling interferes with RSV replication and identified the Raf/MEK/ERK kinase cascade as potential target f...Continue Reading

References

Jan 1, 1990·Pediatric Pathology·K A Neilson, E J Yunis
Feb 13, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·M MonickG Hunninghake
Aug 9, 2001·Proceedings of the National Academy of Sciences of the United States of America·L González-ReyesJ A Melero
Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Mar 22, 2002·The Journal of General Virology·R GhildyalJ Meanger
Jan 15, 2003·Journal of Virology·Lewis H McCurdy, Barney S Graham
May 24, 2003·Proceedings of the National Academy of Sciences of the United States of America·Vincent R HarleyDavid A Jans
Jan 27, 2004·American Journal of Respiratory Cell and Molecular Biology·Martha M MonickGary W Hunninghake
Feb 13, 2004·FEBS Letters·Xiaoyuan KongShyam S Mohapatra
Apr 29, 2005·The New England Journal of Medicine·Ann R FalseyEdward E Walsh
Apr 14, 2006·Journal of Virology·Sarah M BattcockKensuke Hirasawa
Dec 5, 2006·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Joyce E JohnsonBarney S Graham
Aug 19, 2007·Archives of Virology·C CarromeuA M Ventura
Nov 27, 2007·Biochemical and Biophysical Research Communications·Kit-Wei LowRichard J Sugrue
Mar 8, 2008·Expert Review of Vaccines·Alex J Elliot, Douglas M Fleming
Jun 16, 2010·The Journal of Cell Biology·Hesso FarhanHans-Peter Hauri
Jun 2, 2011·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Pratibha GaurSunil K Lal
Feb 10, 2012·Journal of Virology·Ruchira MitraAntonius G P Oomens
Dec 20, 2013·Viruses·Nora Diehl, Heiner Schaal
Aug 4, 2016·Seminars in Respiratory and Critical Care Medicine·Karen BohmwaldAlexis M Kalergis
Sep 24, 2016·Biochemical Pharmacology·Elisabeth HeylenDirk Jochmans
Nov 1, 2017·The Journal of General Virology·Bert Rima Ictv Report Consortium
Jan 13, 2018·Journal of Virology·Jeanne K DuShaneMelissa S Maginnis

❮ Previous
Next ❯

Citations

Feb 16, 2019·International Journal of Molecular Sciences·Grace C A ManleyYongliang Zhang
Jul 20, 2019·Cell Communication and Signaling : CCS·Engin BaturcamDanen Mootoosamy Cunoosamy
Dec 25, 2019·Cold Spring Harbor Perspectives in Medicine·Stephan LudwigYvonne Boergeling

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.